Parkinson’s Drug Injury Attorneys Are Accepting Injury or Wrongful Death Cases Related to the Nuplazid
The experienced drug product attorneys at Parker Waichman LLP are investigating cases involving the Parkinson’s drug Nuplazid and hallucinations, serious falls, and death. If you or a loved one took Nuplazid and experienced a dangerous side effect, contact our office today. Our lawyers provide free, no-obligation case consultations and will begin reviewing your potential case immediately to see if you might be eligible to file a lawsuit against the manufacturer.
EXPERIENCED NUPLAZID INJURY LAWYERS
Parker Waichman’s attorneys have extensive experience litigating dangerous drug products, and we have the skills it takes to stand up to major pharmaceutical manufacturers. Nuplazid has been linked to serious and life-threatening side effects, and we are working to hold the manufacturer accountable. We have secured more than $2 billion in compensation for our clients and will fight for the results you and your family deserve.
Nuplazid Indications and Use
Nuplazid (pimavanserin) is an atypical antipsychotic drug indicated for the treatment of hallucinations and delusions in patients with Parkinson’s disease. The drug is manufactured by Acadia Pharmaceuticals Inc., of San Diego, and has been on the market since its approval by the U.S. Food and Drug Administration (FDA) in 2016.
Approximately 1 million patients in the United States have Parkinson’s disease, according to the FDA, and about half of those patients suffer from Parkinson’s psychosis. Patients with this type of psychosis experience frightening visual and auditory hallucinations and Nuplazid is the first drug approved to treat these hallucinations and delusions. However, the drug has been linked to serious complications.
Nuplazid Side Effects, Injuries and Associated Deaths
Nuplazid has been approved to treat hallucinations and delusions in Parkinson’s patients, but reports show the drug has been linked to a worsening of these disturbances, along with other dangerous side effects. According to information reported to the FDA, Nuplazid can potentially lead to all of the following complications:
- Worsening symptoms of Parkinson’s disease psychosis
- Worsening hallucinations
- Gait instability and difficulty walking or standing
- Serious falls
- Severe fatigue
- Chronic insomnia
Our firm is investigating cases in which patients developed any of these side effects while taking the drug Nuplazid. Contact Parker Waichman LLP today to discuss your potential case.
Nuplazid Not Effective in Treating Hallucinations
Nuplazid was approved by the FDA through a special expedited process because it was designated a “breakthrough therapy.” The basis for this expedited approval was a six-week clinical trial involving about 200 patients. “Breakthrough therapy” drug approval is supposed only to be granted to drugs that demonstrate a significant improvement in clinical trials for patients who are suffering from serious or life-threatening diseases.
However, in its relevant clinical trial, Nuplazid showed minimal, if any, improvement in frequency or intensity of hallucinations in studied patients. Moreover, in its previous three trials, Nuplazid showed no improvement at all in patients taking the drug, compared to patients taking a placebo. In order to receive approval, Nuplazid changed its measuring methods in its last trial to reflect some sort of benefit.
In reality, patients who had taken Nuplazid receive experience no improvement or actually find that their Parkinson’s disease psychosis is worse than before they started taking Nuplazid. These patients were turning to Nuplazid with the hope of escaping terrifying hallucinations, and the drug made them worse. Parker Waichman LLP is fighting back on behalf of patients and families who were counting on the drug that failed them.
Nuplazid Linked to Dangerous Incidents and Falls
The FDA and the Nuplazid drug manufacturer have received reports that patients taking Nuplazid have experienced life-threatening incidents and falls. Patients in multiple age groups taking the drug experience insomnia, gait disturbances, confusion, dizziness, and imbalance. Under these conditions, patients are at serious risk of:
- Car accidents
- Walking into traffic
- Falling down the stairs
- Falling and hitting objects
- Head injury
- Poor decision-making
- Erratic behavior
These incidents can lead to life-threatening injuries. Affected patients and family members are left not knowing what to do next or where to turn. Our firm is working to provide relief to injured people and their families and to secure deserved compensation from the manufacturer of Nuplazid.
Nuplazid Carries Increased Risk of Death
Since the time the drug hit the market, in June 2016, more than 700 people taking Nuplazid have died. The physician who led the FDA’s review of Nuplazid prior to its approval warned of the potential for death while taking the drug. And after the drug was approved and reports of death started coming in, this physician told CNN he expected it to happen. Other researchers are calling the number of deaths “unheard of.”
Currently, the Nuplazid label has a “Black Box” warning — the highest possible warning for a prescription drug label — related to an increased risk of death. However, that warning is for elderly patients with dementia-related psychosis. Nuplazid is not currently approved for treatment of dementia-related psychosis, only for Parkinson’s disease psychosis. Therefore, patients who are taking the drug for its approved use are not being warned about this side effect.
In response to the number of reported deaths in patients taking its drug, Nuplazid manufacturer Acadia says the type of patients taking Nuplazid are already at an increased risk of death because of their Parkinson’s disease and other medical issues. Acadia also attributed the reports to more consistent contact between these patients and their specialty pharmacies. When pharmacies are in greater contact with patients, Acadia said, they learn more often of deaths and in turn report those deaths to the FDA and drug manufacturers.
In the more than 700 deaths of Nuplazid patients, Nuplazid is the only “suspect” drug associated with the vast majority of those deaths, according to data from the FDA. Parker Waichman’s attorneys do not find Acadia’s explanations acceptable, and we are aggressively working to hold this manufacturer responsible for rushing a dangerous drug to market and placing patients at serious risk of injury.
If you are grieving a family member who died while taking the drug Nuplazid, contact Parker Waichman LLP today. Our skilled product liability attorneys will investigate your potential claims and help you receive the justice your loved one deserves.
Statutes of Limitations on Nuplazid Claims
Statutes of limitations pertain to all drug product cases. These statutes are essentially deadlines on filing cases in court. If the statute of limitations on your case expires before you file, your legal rights could be lost.
Our firm works on cases across the nation, and we always carefully analyze statutes of limitations in all cases. Because so many factors — like the nature of a case and damages claimed in the case — can influence the calculation of your statute of limitations, the best way to be sure about your filing deadline is to hire an experienced attorney. Parker Waichman’s lawyers will examine all relevant dates in your case to make sure your rights are protected.
Contact our national plaintiff’s law firm today to discuss your potential Nuplazid claim with a skilled lawyer. Time could be limited in your ability to file a lawsuit, so do not delay in calling our firm.
Contact Parker Waichman LLP for Your Free Nuplazid Case Review
The attorneys at Parker Waichman LLP are committed to achieving justice for people injured by dangerous drugs. If you or a family member have sustained complications while taking the Parkinson’s drug Nuplazid, contact our firm today for a free, no-risk case consultation. You can reach our office by calling 1-800-YOURLAWYER (1-800-968-7529) or by filling out our online form.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Have you or a family member sustained complications while taking the Parkinson’s drug Nuplazid?Click To Get A Free Case Review